Heterogeneity in diagnostic criteria for chronic kidney disease of undetermined etiology (CKDu): a systematic review of the literature
- PMID: 40597920
- PMCID: PMC12219891
- DOI: 10.1186/s12882-025-04258-1
Heterogeneity in diagnostic criteria for chronic kidney disease of undetermined etiology (CKDu): a systematic review of the literature
Abstract
Background: Chronic kidney disease (CKD) of undetermined etiology (CKDu) is an important public health problem. It is a diagnosis of exclusion and the diagnostic approach varies widely across geographies. We aimed to systematically examine criteria used to diagnose CKDu in published literature.
Method: PubMed, Medline, Embase, and Web of Science were searched systematically for published studies and conference abstracts pertaining to CKDu using relevant search terms. Systematic reviews/meta-analyses and reviews were screened to identify additional studies. Findings are presented in tables and figures and discussed critically.
Results: 60 studies were identified which mention the definition used to diagnose CKDu. A combination of pre-specified estimated glomerular filtration rate (eGFR) and proteinuria/albuminuria cut-offs was used as diagnostic criteria in only 18 studies (30%), while another 11 studies (18.3%) relied solely on proteinuria/albuminuria cut-offs.Nineteen studies classified all CKD patients without any identifiable cause as CKDu irrespective of level of proteinuria/albuminuria. 18 studies excluded patients with significant proteinuria/albuminuria, although cut-offs used for exclusion varied. Limited studies mention the criteria used to exclude diabetes(n = 22) and hypertension(n = 23) related kidney disease, the two most common causes of CKD with wide variability.
Conclusions: There is considerable variability in diagnostic criteria used to define CKDu in epidemiologic studies, especially in excluding proteinuria and other causes of kidney disease. Such heterogeneity may cause misclassification and erroneous estimation of disease burden making comparisons between studies difficult.
Clinical trial number: Not applicable.
Keywords: Albuminuria; Chronic Kidney Disease of unknown etiology (CKDu); Diagnostic criteria; Hypertension; Proteinuria; eGFR.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The project was reviewed at the London School of Hygiene and Tropical Medicine through the Combined Academic, Risk assessment and Ethics (CARE) process and being a literature review, was assessed by the Research Governance & Integrity Office as not requiring ethical approval as all data are in the public domain. Consent to participate is not applicable as this is review of previously published studies and does not involve collection and analysis of individual patient data. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Systematic review on urine albumin testing for early detection of diabetic complications.Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300. Health Technol Assess. 2005. PMID: 16095545
-
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3. Cochrane Database Syst Rev. 2023. PMID: 37466151 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210. Health Technol Assess. 2010. PMID: 20441712
-
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2. Cochrane Database Syst Rev. 2018. PMID: 29357120 Free PMC article.
References
-
- Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72. - PubMed
-
- Trabanino RG, Aguilar R, Silva CR, Mercado MO, Merino RL. Nefropatía terminal En Pacientes de Un hospital de referencia En El Salvador [End-stage renal disease among patients in a referral hospital in El salvador]. Rev Panam Salud Publica. 2002;12(3):202–6. - PubMed
-
- Sommar JN, Svensson MK, Björ BM, Elmståhl SI, Hallmans G, Lundh T, Schön SM, Skerfving S, Bergdahl IA. End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden. Environ Health. 2013;12:9. 10.1186/1476-069X-12-9. - PMC - PubMed
-
- Sontrop JM, Dixon SN, Garg AX, Buendia-Jimenez I, Dohein O, Huang SH, Clark WF. Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data. Am J Nephrol. 2013;37(5):434–42. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous